Development of novel anti-viral treatment using primary human hepatocyte and stable isotope.
Project/Area Number |
15K15293
|
Research Category |
Grant-in-Aid for Challenging Exploratory Research
|
Allocation Type | Multi-year Fund |
Research Field |
Gastroenterology
|
Research Institution | Hiroshima University |
Principal Investigator |
CHAYAMA KAZUAKI 広島大学, 医歯薬保健学研究院(医), 教授 (00211376)
|
Project Period (FY) |
2015-04-01 – 2017-03-31
|
Project Status |
Completed (Fiscal Year 2016)
|
Budget Amount *help |
¥3,640,000 (Direct Cost: ¥2,800,000、Indirect Cost: ¥840,000)
Fiscal Year 2016: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2015: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
|
Keywords | B型肝炎ウイルス / ヒト肝細胞 / キメラマウス / Hepg2 / NTCP / HepaRG / HepG2 |
Outline of Final Research Achievements |
We administered mouse food that is used to make stable isotope containing diet. uPA-scid based mouse did not eat this food and weakened. Thus it became clear to create stable isotope labelled primary hepatocyte using this diet. As the diet is quite expensive and difficult to purchase a different diet, we decided to make a different strain of human hepatocyte chimeric mouse. We attempted to establish a human hepatocyte chimeric mouse using different immune deficient mouse strain and succeeded to establish enough human hepatocyte chimerism. We also confirmed to establish stable hepatitis B and hepatitis C virus viremia using this human hepatocyte chimeric mouse. We will try to feed this mouse with stable isotope labelled diet and create labelled primary human hepatocytes.
|
Report
(3 results)
Research Products
(20 results)
-
-
[Journal Article] The relationship between HBcrAg and HBV reinfection in HBV related post-liver transplantation patients.2017
Author(s)
Urabe A, Imamura M, Tsuge M, Kan H, Fujino H, Fukuhara T, Masaki K, Kobayashi T, Ono A, Nakahara T, Kawaoka T, Hiramatsu A, Kawakami Y, Aikata H, Hayes CN, Maki N, Ohdan H, Chayama K.
-
Journal Title
J Gastroenterol.
Volume: 52
Issue: 3
Pages: 366-375
DOI
Related Report
Peer Reviewed / Open Access
-
-
[Journal Article] Antiviral effects of anti-HBs immunoglobulin and vaccine on HBs antigen seroclearance for chronic hepatitis B infection.2016
Author(s)
Tsuge M, Hiraga N, Uchida T, Kan H, Miyaki E, Masaki K, Ono A, Nakahara T, Abe-Chayama H, Zhang Y, Naswa MG, Kawaoka T, Miki D, Imamura M, Kawakami Y, Aikata H, Ochi H, Hayes CN, Chayama K.
-
Journal Title
Journal of Gastroenterology
Volume: In press
Issue: 11
Pages: 1073-1080
DOI
Related Report
Peer Reviewed / Open Access
-
-
[Journal Article] Novel pH-sensitive multifunctional envelope-type nanodevice for siRNA-based treatments for chronic HBV infection2016
Author(s)
Yamamoto, N. Sato, Y. Munakata, T. Kakuni, M. Tateno, C. Sanada, T. Hirata, Y. Murakami, S. Tanaka, Y. Chayama, K. Hatakeyama, H. Hyodo, M. Harashima, H. Kohara, M.
-
Journal Title
Journal of hepatology
Volume: 64
Issue: 3
Pages: 547-455
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research / Acknowledgement Compliant
-
-
[Journal Article] Elimination of HCV via a non-ISG-mediated mechanism by vaniprevir andBMS-788329 combination therapy in human hepatocyte chimeric mice.2016
Author(s)
Uchida T, Hiraga N, Imamura M, Yoshimi S, Kan H, Miyaki E, Tsuge M, Abe H, Hayes CN, Aikata H, Ishida Y, Tateno C, Ellis JD, Chayama K.
-
Journal Title
Virus Res.
Volume: 213
Issue: 1
Pages: 62-68
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research / Acknowledgement Compliant
-
-
-
-
-
-
-
-
-
-
-
-